Form D · Pharmaceuticals

Emerald Health Pharmaceuticals Inc.

San Diego, CA · CIK 0001700800

Offering snapshot reported Jul 8, 2021 · SEC filing

Reported sold
$300K
Indefinite offering
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 8, 2021Initial$300,000No comparisonNot reportedSEC filing
Apr 19, 2021Initial$500,000No comparison1SEC filing
Jun 19, 2019Initial$2,500,000No comparison1SEC filing
Mar 14, 2017Initial$1,000No comparison5SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-405544

Source: Form D, filed Jul 8, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jill Broadfoot Executive
Nancy Coulson Executive
James De Mesa Director, Executive
Jim De Mesa Executive
Avtar S. Dhillon Director, Executive
Punit Dhillon Director
James L. Hepell Director
Jim Heppell Director
James Heppell Director
Gaetano Morello Director
Eduardo Munoz Executive
Alain Rolland Executive
Lisa Sanford Executive
Joachim Schupp Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
5910 Pacific Center Blvd Suite 320
San Diego, CA, 92121